Literature DB >> 6197190

Human natural cytotoxic lymphocytes: definition by a monoclonal antibody of a subset which kills an anchorage-dependent target cell line but not the K-562 cell line.

M Rola-Pleszczynski, H Lieu.   

Abstract

A monoclonal mouse antibody (HNC-1A3) which defines a subset of human lymphocytes with natural cytotoxic activity was produced and studied. HNC-1A3+ cells represent 12 +/- 3% of peripheral blood mononuclear leukocytes. When sorted out using a fluorescence-activated cell sorter, they consist of 60% small lymphocytes, 35% large (predominantly agranular) lymphocytes, and 5% monocytes. They contain 30 +/- 6% E-rosette-forming cells, 6 +/- 1% OKT4+ cells, 17 +/- 6% OKT8+ cells and less than 2% OKT10+ or Leu-7 (HNK-1)+ cells. They are responsible for most of the natural cytotoxic activity against the MA-160 prostatic adenoma cell line but mediate an insignificant amount of cytotoxicity against the NK prototype target K562 cell line. Conversely, Leu-7+ cells which mediate most NK activity against K562 are weakly active against MA-160. Our data suggest a heterogeneity among leukocytes mediating natural cytotoxicity, with restricted specificities for the recognition sites on target cells.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6197190     DOI: 10.1016/0008-8749(83)90166-1

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  3 in total

1.  Human natural cytotoxic cells: distinctive membrane markers and patterns of reactivity.

Authors:  J Stankova; M Rola-Pleszczynski
Journal:  Immunol Res       Date:  1986       Impact factor: 2.829

2.  Membrane markers, target cell specificity, and sensitivity to biological response modifiers distinguish human natural cytotoxic from human natural killer cells.

Authors:  M Rola-Pleszczynski; H Lieu; A K Sullivan; M Girard
Journal:  J Clin Invest       Date:  1985-11       Impact factor: 14.808

3.  Discordance between transferrin receptor expression and susceptibility to lysis by natural killer cells.

Authors:  K R Bridges; B R Smith
Journal:  J Clin Invest       Date:  1985-09       Impact factor: 14.808

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.